These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1329300)

  • 21. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary style and acid load in an Italian population of calcium kidney stone formers.
    Vezzoli G; Dogliotti E; Terranegra A; Arcidiacono T; Macrina L; Tavecchia M; Pivari F; Mingione A; Brasacchio C; Nouvenne A; Meschi T; Cusi D; Spotti D; Montanari E; Soldati L
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):588-93. PubMed ID: 25921845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of diclofenac sodium on urinary concentration of calcium, uric acid and glycosaminoglycans in traumatic paraplegics.
    Sharma S; Vaidyanathan S; Thind SK; Nath R; Sankaranarayanan A
    Br J Urol; 1991 Sep; 68(3):240-2. PubMed ID: 1913063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary sodium excretion in renal stone formers. An epidemiological study.
    Schellenberg B; Tschöpe W; Ritz E; Wesch H; Schlierf G
    Klin Wochenschr; 1980 Jun; 58(11):575-80. PubMed ID: 7392537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diclofenac-Na--an alternative treatment possibility in therapy-resistant calcium oxalate urolithiasis?].
    Brundig P; Pirlich W; Börner RH; Wittig E
    Urologe A; 1986 Jul; 25(4):204-8. PubMed ID: 3765223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers in their forties.
    Naya Y; Ito H; Masai M; Yamaguchi K
    Eur Urol; 2000 Feb; 37(2):140-4. PubMed ID: 10705190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case-control study of risk factors for idiopathic calcium nephrolithiasis.
    Wasserstein AG; Stolley PD; Soper KA; Goldfarb S; Maislin G; Agus Z
    Miner Electrolyte Metab; 1987; 13(2):85-95. PubMed ID: 3696092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities.
    Laminski NA; Meyers AM; Sonnekus MI; Smyth AE
    Nephron; 1990; 56(4):379-86. PubMed ID: 1964200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary pyrophosphate excretion in stone formers.
    Singh DP; Teotia M; Teotia SP; Nath M
    Indian J Med Res; 1985 Oct; 82():341-5. PubMed ID: 3000936
    [No Abstract]   [Full Text] [Related]  

  • 36. Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice.
    Caballero D; Li Y; Fetene J; Ponsetto J; Chen A; Zhu C; Braddock DT; Bergwitz C
    PLoS One; 2017; 12(7):e0180098. PubMed ID: 28704395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function.
    Sutton RA; Walker VR
    N Engl J Med; 1980 Mar; 302(13):709-13. PubMed ID: 7354777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.